Innovent

blocks stack target climb build arrow meet

Awaiting regulator verdict, Innovent posts latest psoriasis win

Innovent has posted another win for its IL-23 contender to the likes of Tremfya and Skyrizi while the company awaits a decision by Chinese regulators.

James Waldron Oct 29, 2024 9:50am

Graphic image of an arrow nailing the bullseye of a target

Innovent bags another phase 3 win for next-gen Lilly GLP-1 drug

Jul 22, 2024 5:31am

skin cells epidermis layers lotion serum

Innovent looks to Chinese regulators after ph. 3 psoriasis win

May 28, 2024 7:55am

On target clinical trial success bullseye score

Lilly's next-gen obesity drug brings Innovent ph. 3 diabetes win

May 9, 2024 7:20am

BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

May 3, 2024 8:30am

Innovent's anti-VEGF drug matches Eylea in eye disease trial

Mar 19, 2024 10:36am